Potential two-step proteomic signature for Parkinson’s disease: Pilot analysis in the Harvard Biomarkers Study.

Potential two-step proteomic signature for Parkinson’s disease: Pilot analysis in the Harvard Biomarkers Study.
Related ArticlesPotential two-step proteomic signature for Parkinson's disease: Pilot analysis in the Harvard Biomarkers Study. Alzheimers Dement (Amst). 2019 Dec;11:374-382 Authors: O'Bryant SE, Edwards M, Zhang F, Johnson LA, Hall J, Kuras Y, Scherzer CR Abstract Introduction: We sought to determine if our previously validated proteomic profile for detecting Alzheimer's disease would detect Parkinson's disease (PD) and distinguish PD from ... read more
Source: PubMedPublished on 2019-05-14